4 Endometrial Cancer Clinical Trials in Anchorage, AK (2026)

Q: How do I join a clinical trial in Anchorage?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Anchorage research site will contact you.

Recruiting Endometrial Cancer Studies in Anchorage

NCT06952504Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. * EC is a type of cancer that starts in the tissues ...

Anchorage, AKPHASE31,123 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05640999Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

This protocol tests de-escalated adjuvant treatment in patients with POLE-mutated or p53wt/NSMP (p53 wildtype/no specific molecular profile) early-stage endometrial cancer (EC). Patients may be enroll...

Anchorage, AKPHASE2393 participantsCanadian Cancer Trials Group

View Study Details

NCT05548296Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial cancer....

Anchorage, AKPHASE2350 participantsAcrivon Therapeutics

View Study Details

NCT07198074Recruiting

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

This phase III trial compares the effect of bevacizumab in combination with carboplatin, paclitaxel and pembrolizumab to the usual treatments of carboplatin and paclitaxel with or without pembrolizuma...

Anchorage, AKPHASE3255 participantsNational Cancer Institute (NCI)

View Study Details

About Endometrial Cancer Clinical Trials in Anchorage

Endometrial cancer begins in the lining of the uterus and is the most common gynecologic cancer. It is often detected early due to abnormal bleeding symptoms. Treatment typically involves surgery, with radiation, chemotherapy, or hormone therapy for advanced cases.

There are currently 4 endometrial cancer clinical trials recruiting participants in Anchorage, AK. These studies are seeking a combined 2,121 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Canadian Cancer Trials Group, Acrivon Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Endometrial Cancer Clinical Trials in Anchorage — FAQ

Are there endometrial cancer clinical trials in Anchorage?

Yes, there are 4 endometrial cancer clinical trials currently recruiting in Anchorage, AK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Anchorage?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Anchorage research site will contact you about next steps.

Are clinical trials in Anchorage free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Anchorage studies also compensate for your time and travel.

What endometrial cancer treatments are being tested?

The 4 active trials in Anchorage are testing new therapies including novel drugs, biologics, and treatment approaches for endometrial cancer.

Data updated July 18, 2026 from ClinicalTrials.gov